Can support clinically meaningful weight loss and metabolic improvement for eligible patients while nutrition, activity and muscle preservation remain active parts of care.
WEIGHT & METABOLIC HEALTH / PRACTITIONER-GUIDED
GLP-1–based medications
FDA-approved medications may be considered for specific diabetes or chronic weight-management indications after clinical evaluation.Create account & prepare for review →Florida pilot planned · A prescription is never guaranteed.
Strong human evidence for approved products and indications; individual benefits and risks vary.
Prescription required; product-specific FDA indications
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓Eligibility is established from medical history and objective measures
- ✓Contraindications and interacting conditions are reviewed
- ✓Follow-up, nutrition and side-effect monitoring are available
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- →Weight history and prior attempts
- →Diabetes, pancreatic, gallbladder and GI history
- →Current medications, pregnancy plans and relevant laboratory context
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !No prescription is guaranteed.
- !Compounded products are not FDA-approved and are not interchangeable with approved drugs.
- !Severe or persistent symptoms require prompt clinician contact.
ORIGINAL SOURCES